about
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteriaClinical proteomics of enervated neuronsGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.The expanded spectrum of neuromyelitis optica: evidences for a new definition.Neuromyelitis optica in Brazil: a study on clinical and prognostic factors.Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients.NMO in pediatric patients: brain involvement and clinical expression.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.A 17 year-old girl with a demyelinating disease requiring mechanical ventilation: a case report.A Case Study of Intractable Vomiting with Final Diagnosis of Neuromyelitis OpticaNeuromyelitis optica in a Ugandan woman: a case report.Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosisNeuromyelitis optica-IgG testing in an Indian cohort with neuromyelitis optica and related demyelinating disorders: Our experience.Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.Neuromyelitis Optica in a Nepalese Man.Enhancing Brain Lesions during Acute Optic Neuritis and/or Longitudinally Extensive Transverse Myelitis May Portend a Higher Relapse Rate in Neuromyelitis Optica Spectrum Disorders.Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease.Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics.Neuromyelitis optica immunoglobulin G in Chinese patients detected by immunofluorescence assay on a monkey brain substrate.NMO-DBr: the Brazilian Neuromyelitis Optica Database System.Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica.
P2860
Q24605493-D6924AFB-E814-4524-9AE7-1E5385FA51C5Q26752052-2EC069D0-FABD-4E86-B69F-92A3A44D3BF7Q30276550-11362349-3906-4074-9EB2-159904ED5E4BQ30573084-3DB7F790-22E5-4D8E-9147-D469B00481B1Q33419781-764B60DB-3CBB-4ABB-A3F6-667748AC1EE1Q33497345-D6C7A75A-A9D4-4DC7-96A9-C3AD6B10AA39Q33832182-B65E7070-7A72-401F-8C7E-72AC83FF5326Q34122035-E8C1210E-9E98-4DC3-8796-3FEBEFCBA05CQ34554399-155D99FD-4E70-4B2F-8906-7486E400C013Q36174210-3BCE7DD2-223B-4B1E-BC21-BFC042B2401FQ37003931-0896F857-15CF-4755-A7BA-B3FCA9535758Q37052797-DC292605-FE97-408B-A372-9E57E0E3A122Q37210403-C3C418AC-A4C5-4C0A-9E16-1BF828DCC0B0Q37598316-31BDDE7B-9C6C-4B6E-AF36-1993E7CF9FDFQ41452025-1F04E5C3-BC55-4307-A609-B712835D75ABQ43067194-49A94AB4-CD0B-4064-84C1-1C8E9DB61896Q43752309-36189FC4-14ED-4FB0-AE81-56BE07173BFEQ44713880-F12637B0-7F76-4A8E-950E-3FB6A76C9C80Q45231803-6C1DA857-12CA-47F6-A864-3E3B8419C325Q45918037-BE28E640-1ED4-4B78-AFF8-BEFCDC492630Q53018455-D76156D7-6A10-493D-9201-05266244269F
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Devic's neuromyelitis optica: a critical review.
@ast
Devic's neuromyelitis optica: a critical review.
@en
type
label
Devic's neuromyelitis optica: a critical review.
@ast
Devic's neuromyelitis optica: a critical review.
@en
prefLabel
Devic's neuromyelitis optica: a critical review.
@ast
Devic's neuromyelitis optica: a critical review.
@en
P2860
P1476
Devic's neuromyelitis optica: a critical review.
@en
P2093
Marco Aurélio Lana-Peixoto
P2860
P304
P356
10.1590/S0004-282X2008000100034
P577
2008-03-01T00:00:00Z